189 related articles for article (PubMed ID: 12581735)
1. Altered response of vascular smooth muscle cells to exogenous biochemical stimulation in two- and three-dimensional culture.
Stegemann JP; Nerem RM
Exp Cell Res; 2003 Feb; 283(2):146-55. PubMed ID: 12581735
[TBL] [Abstract][Full Text] [Related]
2. Phenotype modulation in vascular tissue engineering using biochemical and mechanical stimulation.
Stegemann JP; Nerem RM
Ann Biomed Eng; 2003 Apr; 31(4):391-402. PubMed ID: 12723680
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin.
Orlandi A; Ropraz P; Gabbiani G
Exp Cell Res; 1994 Oct; 214(2):528-36. PubMed ID: 7925646
[TBL] [Abstract][Full Text] [Related]
4. Pericyte growth and contractile phenotype: modulation by endothelial-synthesized matrix and comparison with aortic smooth muscle.
Newcomb PM; Herman IM
J Cell Physiol; 1993 May; 155(2):385-93. PubMed ID: 8482730
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-7 (osteogenic protein-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro.
Dorai H; Vukicevic S; Sampath TK
J Cell Physiol; 2000 Jul; 184(1):37-45. PubMed ID: 10825232
[TBL] [Abstract][Full Text] [Related]
6. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures.
Majack RA
J Cell Biol; 1987 Jul; 105(1):465-71. PubMed ID: 3475277
[TBL] [Abstract][Full Text] [Related]
7. Effects of transforming growth factor-beta 1 on growth of aortic smooth muscle cells. Influences of interaction with growth factors, cell state, cell phenotype, and cell cycle.
Morisaki N; Kawano M; Koyama N; Koshikawa T; Umemiya K; Saito Y; Yoshida S
Atherosclerosis; 1991 Jun; 88(2-3):227-34. PubMed ID: 1892488
[TBL] [Abstract][Full Text] [Related]
8. Modulation of smooth muscle cell behaviour by platelet-derived factors and the extracellular matrix.
Wren FE; Schor AM; Schor SL; Grant ME
J Cell Physiol; 1986 May; 127(2):297-302. PubMed ID: 3700485
[TBL] [Abstract][Full Text] [Related]
9. Growth factor regulation of smooth muscle actin expression and contraction of human articular chondrocytes and meniscal cells in a collagen-GAG matrix.
Zaleskas JM; Kinner B; Freyman TM; Yannas IV; Gibson LJ; Spector M
Exp Cell Res; 2001 Oct; 270(1):21-31. PubMed ID: 11597124
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 modulates extracellular matrix production, proliferation, and apoptosis of endothelial progenitor cells in tissue-engineering scaffolds.
Sales VL; Engelmayr GC; Mettler BA; Johnson JA; Sacks MS; Mayer JE
Circulation; 2006 Jul; 114(1 Suppl):I193-9. PubMed ID: 16820571
[TBL] [Abstract][Full Text] [Related]
11. Retardation of phenotypic transition of rabbit arterial smooth muscle cells in three-dimensional primary culture.
Yamamoto M; Nakamura H; Yamato M; Aoyagi M; Yamamoto K
Exp Cell Res; 1996 May; 225(1):12-21. PubMed ID: 8635504
[TBL] [Abstract][Full Text] [Related]
12. Efficient generation of smooth muscle cells from adipose-derived stromal cells by 3D mechanical stimulation can substitute the use of growth factors in vascular tissue engineering.
Parvizi M; Bolhuis-Versteeg LA; Poot AA; Harmsen MC
Biotechnol J; 2016 Jul; 11(7):932-44. PubMed ID: 26989865
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression.
Vernon SM; Campos MJ; Haystead T; Thompson MM; DiCorleto PE; Owens GK
Am J Physiol; 1997 Feb; 272(2 Pt 1):C582-91. PubMed ID: 9124302
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell matrices modulate smooth muscle cell growth, contractile phenotype and sensitivity to heparin.
Herman IM
Haemostasis; 1990; 20 Suppl 1():166-77. PubMed ID: 2083870
[TBL] [Abstract][Full Text] [Related]
15. Vascular smooth muscle cells as a valvular interstitial cell surrogate in heart valve tissue engineering.
Appleton AJ; Appleton CT; Boughner DR; Rogers KA
Tissue Eng Part A; 2009 Dec; 15(12):3889-97. PubMed ID: 19563261
[TBL] [Abstract][Full Text] [Related]
16. Genetic modification of smooth muscle cells to control phenotype and function in vascular tissue engineering.
Stegemann JP; Dey NB; Lincoln TM; Nerem RM
Tissue Eng; 2004; 10(1-2):189-99. PubMed ID: 15009945
[TBL] [Abstract][Full Text] [Related]
17. Heparin and the phenotype of adult human vascular smooth muscle cells.
Sorger T; Friday N; Yang LD; Levine EM
In Vitro Cell Dev Biol Anim; 1995 Oct; 31(9):671-83. PubMed ID: 8564078
[TBL] [Abstract][Full Text] [Related]
18. Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules.
Cushing MC; Liao JT; Anseth KS
Matrix Biol; 2005 Sep; 24(6):428-37. PubMed ID: 16055320
[TBL] [Abstract][Full Text] [Related]
19. Rat vascular smooth muscle cells immortalized with SV40 large T antigen possess defined smooth muscle cell characteristics including growth inhibition by heparin.
Reilly CF
J Cell Physiol; 1990 Feb; 142(2):342-51. PubMed ID: 2154504
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic factors released from smooth muscle cells are responsible for neointimal cell proliferation after balloon catheter deendothelialization.
Li Z; Moore S; Alavi MZ
Exp Mol Pathol; 1995 Oct; 63(2):77-86. PubMed ID: 8941042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
